Teleflex/$TFX

13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX

About Teleflex

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Ticker

$TFX

Primary listing

NYSE

Industry

Health Care Equipment & Supplies

Employees

14,100

ISIN

US8793691069

Teleflex Metrics

BasicAdvanced
$5B
35.48
$3.20
1.08
$1.36
1.20%

What the Analysts think about Teleflex

Analyst ratings (Buy, Hold, Sell) for Teleflex stock.

Bulls say / Bears say

Teleflex reported a 2.4% increase in third-quarter revenue to $764.4 million, driven by strong demand for its medical devices, particularly in the vascular access segment, which saw sales rise by 6.5% to $180.9 million. (reuters.com)
The company raised its 2024 adjusted profit forecast to between $13.80 and $14.20 per share, up from the previous outlook of $13.60 to $13.95, reflecting confidence in sustained demand for surgical procedures utilizing its devices. (reuters.com)
Teleflex completed the acquisition of Palette Life Sciences for $594.9 million, aiming to expand its product offerings and market reach, which could drive future revenue growth. (secsense.ai)
In the first quarter of 2025, Teleflex reported a 5.0% decline in revenue to $700.7 million compared to the same period in 2024, indicating potential challenges in maintaining growth momentum. (santelog.com)
The company recognized a $240 million goodwill impairment charge in its Interventional Urology segment, primarily due to a prolonged period of subdued revenue growth and increased competitive pressures. (secsense.ai)
Teleflex's debt-to-equity ratio stands at 47.1%, with total debt of $1.9 billion, which may raise concerns about the company's leverage and financial flexibility. (simplywall.st)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.

Teleflex Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Teleflex Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $TFX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs